Dehydroepiandrosterone sulfate and growth axis hormones in patients after surgery

World Journal of Surgery

Volumn 26, Issue 9, 2002, Pages 1079-1082

  Osorio, Alvaro ^a   Vara Thorbeck, Rafael ^a   Rosell, Jorge ^a   Osorio, Carlos ^a   Ortega, Esperanza ^a   Ruiz Requena, Estrella ^a  

^a UNIVERSITY OF GRANADA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN; GROWTH HORMONE; HYDROCORTISONE; PRASTERONE SULFATE; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; HUMAN GROWTH HORMONE;

ADULT; ARTICLE; CHOLECYSTECTOMY; CHRONIC DISEASE; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; FEMALE; FOLLOW UP; GENDER; HORMONAL REGULATION; HORMONE BLOOD LEVEL; HORMONE DETERMINATION; HUMAN; INJURY; LIFE EXPECTANCY; MALE; PATIENT SELECTION; POSTOPERATIVE CARE; PREOPERATIVE PERIOD; SEX DIFFERENCE; STATISTICAL SIGNIFICANCE; SURGICAL STRESS; BLOOD; CHOLELITHIASIS; MIDDLE AGED; POSTOPERATIVE PERIOD; PROSPECTIVE STUDY; STRESS;

ADRENOCORTICOTROPIC HORMONE; ADULT; CHOLECYSTECTOMY; CHOLELITHIASIS; DEHYDROEPIANDROSTERONE SULFATE; FEMALE; HUMAN GROWTH HORMONE; HUMANS; HYDROCORTISONE; INSULIN-LIKE GROWTH FACTOR I; MALE; MIDDLE AGED; POSTOPERATIVE PERIOD; PROSPECTIVE STUDIES; STRESS;

EID: 0036717197     PISSN: 03642313     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00268-002-6368-7     Document Type: Article

References (33)

1. Belanger A, Candas B, Dupont A, et al. Changes in serum concentrations of conjugated and inconjugated steroids in 40-to-80 year old men. J. Clin. Endocrinol. Metab. 1994;79:1086-1090
2. Labrie F, Belanger A, Cusan L, et al. Physiological changes in dehydroepiandrosterone are not reflected by serum levels of active androgens and estrogens but of their metabolites: intracrinology. J. Clin. Endocrinol. Metab. 1997;82:2403-2409
3. Corpas E, Harman M, Blacman MR. Human growth hormone and human aging. Endocr. Rev. 1993;14:20-39
4. Yen SS, Morales AJ, Khorram O. Replacement of DHEA in aging men and women: potential remedial effects. Ann. N.Y. Acad. Sci. 1995;774:128-142
5. Morales AJ, Haubrich RH, Hwang JY, et al. The effect of six months treatment with a 100 mg daily dose of dehydroepiandrosterone (DHEA) on circulating sex steroids, body composition and muscle strength in age-advanced men and women. Clin. Endocrinol. (Oxf.) 1998;49:421-432
6. Vara-Thorbeck R, Guerrero JA, Ruiz Requena ME, et al. Effect of growth hormone in patients receiving total parenteral nutrition following major gastrointestinal surgery. Hepatogastroenterology 1992; 39:270-272
7. Vara-Thorbeck R, Guerrero JA, Rosell J, et al. Exogenous growth hormone: effects on the catabolic response to surgically produced acute stress and on postoperative immune function. World J. Surg. 1993;17:530-537
8. Vara-Thorbeck R, Ruiz-Requena E, Guerrero-Fernandez JA. Effects of human growth hormone on the catabolic state after surgical trauma. Horm. Res. 1996;45:55-60
9. Vara-Thorbeck R, Guerrero JA, Ruiz-Requena E, et al. Can the use of growth hormone reduce the postoperative fatigue syndrome? World J. Surg. 1996;20:81-86
10. Parker LN, Levin ER, Lifrak ET. Evidence for adrenocortical adaptation to severe illness. J. Clin. Endocrinol. Metab. 1985;60:947-952
11. Khaw KT. Dehydroepiandrosterone, dehydroepiandrosterone sulfate, and cardiovascular disease. J. Endocrinol. 1996;150(Suppl.):S149-S153
12. Stahl F, Schnorr D, Pilz C, et al. Dehydroepiandrosterone (DHEA) levels in patients with prostatic cancer, heart diseases and under surgery stress. Exp. Clin. Endocrinol. 1992;99:68-70
13. Lindh A, Carlström K, Eklund J, et al. Serum steroids and prolactin during and after major surgical trauma. Acta Anaesthesiol. Scand. 1992;36:119-124
14. Adami HO, Axelsson O, Carlström K, et al. Serum levels of cortisol, dehydroepiandrosterone, dehydroepiandrosterone sulphate, estrone and prolactin after surgical trauma in postmenopausal women. Ups. J. Med. Sci. 1982;87:201-213
15. Batrinos ML, Patnisa-Faflia C, Koutsoumanis C, et al. Surgical stress induces a marked and sustained increase of adrenal androgen secretion in postmenopausal women. In Vivo 1999;13:147-150
16. Cooper CE, Nelson DH. ACTH levels in plasma in preoperative and surgical stressed patients. J. Clin. Invest. 1985;14:14-21
17. Udelsman R, Norton JA, Jelenich SE, et al. Responses of the hypothalamic-pituitary-adrenal and renin-angiotensin axes and the sympathetic system during controlled surgical and anesthetic stress. J. Clin. Endocrinol. Metab. 1987;64:986-994
18. Raff H, Norton AJ, Flemma RJ, et al. Inhibition of the adrenocorticotropin response to surgery in humans: interaction between dexamethasone and fentanyl. J. Clin. Endocrinol. Metab. 1987;65:295-298
19. Rittmaster RS, Cutler GB Jr, Sobel DO, et al. Morphine inhibits the pituitary-adrenal response to ovine corticotropin-releasing hormone in normal subjects. J. Clin. Endocrinol. Metab. 1974;38:736-741
20. Orentreich N, Brind JL, Vogelman JH, et al. Long-term longitudinal measurements of plasma dehydroepiandrosteronesulfate in normal men. J. Clin. Endocrinol. Metab. 1992;74:1002-1004
21. Zummoff B, Walsh BT, Katz JL, et al. Subnormal plasma dehydroepiandrosterone to cortisol ratio in anorexia nervosa a secondary hormonal parameter of ontogenic regresion. J. Clin. Endocrinol. Metab. 1983;56:668-673
22. Mackenzie JS, Burrows L, Burchard KW. Transient hypoadrenalism during surgical critical illness. Arch. Surg. 1998;133:199-204
23. Jeevanadam M, Ramias L, Shamos RF, et al. Decreased growth hormone levels in the catabolic phase of severe injury. Surgery 1992; 111:495-502
24. Wright PD, Johnston IDA. The effect of surgical operation on growth hormone levels in plasma. Surgery 1975;77:479-486
25. Jiang Z, He G-Z, Zhang S-Y, et al. Low-dose growth hormone and hypocaloric nutrition attenuate the protein-catabolic response after major operation. Ann. Surg. 1989;210:513-525
26. Cotterill AM, Mendel P, Holly JMP, et al. The differential regulation of the circulating levels of the insulin-like growth factor binding protein (1GFBP) 1, 2 and 3 after elective abdominal surgery. Clin. Endocrinol. (Oxf.) 1996;44:91-101
27. Miell JP, Taylor AM, Jones J, et al. Administration of human recombinant insulin-like growth factor-1 to patients following major gastrointestinal surgery. Clin. Endocrinol. (Oxf.) 1992;37:542-551
28. Blat C, Villudy J, Binoux M. In vivo proteolysis of serum insulin-like growth factor (IGF) binding protein-3 results in increased availability of IGF to target cells. J. Clin. Invest. 1994;93:2286-2290
29. Lassare C, Binoux M. Insulin-like growth factor binding protein 3 is functionally altered in pregnancy plasma. Endocrinology 1994;134: 1254-1262
30. Cwyfan-Huges SC, Cotterill AM, Molloy AR, et al. The induction of specific proteases for insulin-like growth factor-binding proteins following major heart surgery. J. Endocrinol. 1992;135:135-145
31. Davenport ML, Isley WL, Pucilowska JB, et al. Insulin-like growth factor protein-3 proteolysisis induced after elective surgery. J. Clin. Endocrinol. Metab. 1992;75:590-595
32. Nippoldt TB, Nair KS. Is there a case for DHEA replacement? Baillieres Clin. Endocrinol. Metab. 1998;12:507-520
33. Casson PR, Anderson RN, Herrod HG, et al. Oral dehydro-epiandrosterone in physiologic doses modulates immune function in postmenopausal women. Am. J. Obstet. Gynecol. 1993;169:1536-1539